ITEOS THERAPEUTICS INC(NASDAQ:ITOS) stock News

ITOS Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Halper Sadeh LLP - Mentions: KLG

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and KLG on Behalf of Shareholders

14 days ago - By: Kahn Swick & Foti, LLC

ITEOS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc. - ITOS

a month ago - By: Halper Sadeh LLC - Mentions: VBTX TTNP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025

a month ago - By: Rowley Law PLLC

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of iTeos Therapeutics, Inc.

a month ago - By: Halper Sadeh LLC - Mentions: ZIMV SPTN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, SPTN on Behalf of Shareholders

a month ago - By: Brodsky & Smith LLC - Mentions: ZIMV PCHM NVEE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: iTeos Therapeutics, Inc. (Nasdaq - ITOS), ZimVie Inc. (Nasdaq - ZIMV), PharmChem, Inc. (OTC - PCHM), NV5 Global, Inc. (Nasdaq - NVEE)

a month ago - By: Halper Sadeh LLC - Mentions: CIO SNV

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, CIO, SNV on Behalf of Shareholders

a month ago - By: Halper Sadeh LLC - Mentions: ZIMV TASK OLO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, TASK, OLO on Behalf of Shareholders

a month ago - By: Kahn Swick & Foti, LLC

ITEOS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc. - ITOS

a month ago - By: Yahoo Finance - Mentions: REPL JNJ ROG

Replimune drug rejected by FDA; Omega raises $647M biotech fund

a month ago - By: Halper Sadeh LLC - Mentions: ZIMV

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders

a month ago - By: Halper Sadeh LLC

ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders

a month ago - By: iTeos Therapeutics Inc.

iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right

a month ago - By: iTeos Therapeutics Inc.

iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right

2 months ago - By: Yahoo Finance

iTeos Therapeutics (ITOS): An Example of Biotech Liquidations

3 months ago - By: Zacks Investment Research

iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know

3 months ago - By: Benzinga - Mentions: SPRO SSII WORX OGEN ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

3 months ago - By: Benzinga - Mentions: LVWR MNRO ANF HEI ...

Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday

3 months ago - By: iTeos Therapeutics Inc.

iTeos Therapeutics Announces Its Intention to Wind Down Operations

3 months ago - By: iTeos Therapeutics Inc.

iTeos Therapeutics Announces Its Intention to Wind Down Operations

3 months ago - By: Yahoo Finance - Mentions: C INTU CALF BUL ...

Citi sells Polish consumer business to VeloBank

3 months ago - By: Yahoo Finance - Mentions: PFE DHI CMG

Cancer drugmaker iTeos to shut down

4 months ago - By: Zacks Investment Research - Mentions: GSK NVS

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

4 months ago - By: Yahoo Finance - Mentions: GSK AZN GILD AMGN ...

Is GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?

4 months ago - By: iTeos Therapeutics Inc.

iTeos annonce les premiers résultats provisoires de l’étude GALAXIES Lung-201 portant sur l’association belrestotug + dostarlimab en traitement de première intention des patients atteints d’un cancer du poumon non à petites cellules et présentant un taux

4 months ago - By: iTeos Therapeutics Inc.

iTeos verkündet Topline-Zwischenergebnisse der GALAXIES Lung-201-Studie für die First-Line-Behandlung mit Belrestotug und Dostarlimab von Krebspatienten, die von einem nicht-kleinzelligen Lungenkarzinom mit hoher PD-L1-Expression betroffen sind

4 months ago - By: Bloomberg

GSK, iTeos End Development of Experimental Lung Cancer Drug

4 months ago - By: iTeos Therapeutics Inc.

iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

4 months ago - By: iTeos Therapeutics Inc.

iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

ITEOS THERAPEUTICS INC (ITOS) Stock News

ITOS Latest News, Press Relases and Analysis